Your browser doesn't support javascript.
loading
Pain Medication and Pain Intensity Following Hip Fractures-Analyses Based on the ProFem Cohort Study.
Jobski, Kathrin; Ritschel, Michaela; Pöggel-Krämer, Katja; Anheier, Daniela; Haastert, Burkhard; Gontscharuk, Veronika; Arend, Werner; Baltes, Marion; Stephan, Astrid; Meyer, Gabriele; Klüppelholz, Birgit; Windolf, Joachim; Thelen, Simon; Jaekel, Carina; Andrich, Silke; Icks, Andrea; Hoffmann, Falk.
Afiliación
  • Jobski K; Department of Health Services Research, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.
  • Ritschel M; Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Pöggel-Krämer K; Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Anheier D; Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Haastert B; Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Gontscharuk V; mediStatistica, Wuppertal, Germany.
  • Arend W; Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Baltes M; Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Stephan A; Martin Luther University Halle-Wittenberg, Institute for Health and Nursing Sciences, Medical Faculty, Halle (Saale), Germany.
  • Meyer G; Department of Nursing Science, Uniklinik RWTH Aachen, Aachen, Germany.
  • Klüppelholz B; Martin Luther University Halle-Wittenberg, Institute for Health and Nursing Sciences, Medical Faculty, Halle (Saale), Germany.
  • Windolf J; Department of Nursing Science, Uniklinik RWTH Aachen, Aachen, Germany.
  • Thelen S; Martin Luther University Halle-Wittenberg, Institute for Health and Nursing Sciences, Medical Faculty, Halle (Saale), Germany.
  • Jaekel C; Department of Health Management, AOK Rheinland/Hamburg, Düsseldorf, Germany.
  • Andrich S; Department of Orthopaedics and Trauma Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Icks A; Department of Orthopaedics and Trauma Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Hoffmann F; Department of Orthopaedics and Trauma Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
Pharmacoepidemiol Drug Saf ; 33(8): e5865, 2024 08.
Article en En | MEDLINE | ID: mdl-39135487
ABSTRACT

PURPOSE:

Pain is a common symptom following proximal femoral fractures (PFF), however, information on its treatment in terms of agents and type of use (scheduled vs. pro re nata [PRN]) is scarce. The main objective of this study was to examine pain medication regimens according to pain intensity following PFF. Furthermore, we explored the utilization of medication plans.

METHODS:

The "ProFem"-study on healthcare provision, functional ability, and quality of life after PFF is a German population-based prospective cohort study based on statutory health insurance data and individually linked survey data from different time points including information on the currently used medication. This present analysis refers to the participants' baseline interviews (about 3 months following PFF) conducted from 2018 to 2019 in the participants' private surroundings.

RESULTS:

The study population comprised 444 participants (mean age 81.2 years, 71.0% female). Half of them reported high intensity pain, and the mean value for the EuroQol visual analogue scale was 50.8. Most commonly used analgesics were metamizole and tilidine/naloxone. Among participants with high intensity pain, 21.9% received only PRN pain medication and 17.2% no pain medication at all. Overall, 61.5% of participants presented any (printed) medication plan and only 25.2% a "federal standardized medication plan" (BMP).

CONCLUSION:

As a substantial number of patients reports high intensity pain about 3 months following a PFF, the large proportion of those receiving no or only PRN pain medication raises questions regarding the appropriateness of the therapy. The overall low utilization of the BMP indicates potential for improvement.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dolor / Dimensión del Dolor / Fracturas de Cadera / Analgésicos Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dolor / Dimensión del Dolor / Fracturas de Cadera / Analgésicos Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido